Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Cancer Metastatic × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 239 Stomach Neoplasms 182 Rectal Neoplasms 161 Pancreatic Neoplasms 115 Colonic Neoplasms 107 Neoplasm Metastasis 63 Esophageal Neoplasms 57 Carcinoma, Hepatocellular 39 Neoplasms 38 Cholangiocarcinoma 31 Adenocarcinoma 31 Adenocarcinoma Of Esophagus 29 Biliary Tract Neoplasms 23 Liver Neoplasms 21 Recurrence 18 Gallbladder Neoplasms 18 Lymphoma, Large B-Cell, Diffuse 16 Gastrointestinal Neoplasms 16 Breast Neoplasms 15 Peritoneal Neoplasms 14 Esophageal Squamous Cell Carcinoma 14 Carcinoma, Non-Small-Cell Lung 13 Bile Duct Neoplasms 11 Locally Advanced Rectal Cancer 9 Unspecified Adult Solid Tumor, Protocol Specific 7 Colorectal Cancer Metastatic 7 Appendiceal Neoplasms 7 Ovarian Neoplasms 6 Lymphoma, Extranodal NK-T-Cell 6 Hodgkin Disease 6

Interventions

Gemcitabine 2 toripalimab 1 surufatinib 1 sintilimab 1 folfirinox 1 chloroquine diphosphate 1 balstilimab 1 Taxes 1 Oxaliplatin 1 Irinotecan 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Cisplatin 1 Chloroquine 1 Celecoxib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04469556 2026-02-20

PASS-01

University Health Network, Toronto

Phase 2 Completed

Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡